In vitro transforming potential, intracellular signaling properties, and sensitivity to a kinase inhibitor (sorafenib) of RET proto-oncogene variants Glu511Lys, Ser649Leu, and Arg886TrpHugo Prazeres, Paula Soares|Endocrine Related Cancer|2011Cited by 13